Links

Homepage

Stock List

Search by Ticker

News

Login

Laboratory Corporation Of Ameri (NYSE:LH)
Stock Analysis

LH224.7
▲ 1.3%2.88

Stock Analysis

The following stock analysis is based on 10.1 years of data (i.e. since Feb 08, 2013). All the stock history has been downloaded.

Stock Exchange

Laboratory Corporation Of Ameri trades on the NYSE exchange in USD dollars.

Sector

It is in the sector.

Current Status of Laboratory Corporation Of Ameri

It is currently trading at $224.7 ($221.82 the previous day).It pays a 0.97% dividend.

Financials

The next reporting date is in 27 days (2023 04 27).

CNN estimates profits for the upcoming quarter will be $3.97 per share ($3.7B). The current Canada / US exchange rate is 1.3551.



Over the past 12 months, $20425 worth of shares have been purchased and $16702312 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 6.3% per year assuming steady exponential growth. The actual 5 year average is 10.6. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year238.47020833333-15.1- Below Average
2 year280.8613402061943.5+ Above Average
3 year195.6594366197217.3+ Above Average
4 year166.844029192552.5- Below Average
5 year162.819695817494.8- Below Average
Laboratory Corporation Of Ameri is projected by analysts to get to $290.00 within the next 12 months (29.1%), but preticted targets range from as high as $300.00 (33.5%) and as low as $260(15.7%).

Risk

The worst drop it has had in recent years is -46.6%. It has a shape to the stock curve, which means

Stock shape test

DAYS AG0PRICE
10219.1RISING
30242.39DROPPING
60255.59DROPPING
150211.71RISING
365273.96DROPPING
800213.55RISING
1200171.68RISING
1600171.46RISING
2000152.18RISING


With an average increase of 6.3% year over year, if Laboratory Corporation Of Ameri is bought at the worst time, Stockmarketizer analysts estimate it will take 88.8 months before the stock will recover to the original purchase price. The P/E value is 16.08.

Tradingview BuySell Widget

Yahoo News Feed

Here's Why Investors Should Retain LabCorp (LH) Stock for Now

Tue, 14 Mar 2023 16:46:04 Investors are optimistic about LabCorp (LH) backed by strength in its Drug Development business.... Read Full Article

LabCorp (LH) Focuses on High-Growth Areas Amid Currency Woe

Wed, 08 Mar 2023 15:18:03 In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neurodegenerative, autoimmune and liver disease as well as cell and gene therapy.... Read Full Article

Top Stock Reports for TotalEnergies, America Movil and Palo Alto Networks

Mon, 06 Mar 2023 17:51:05 Today's Research Daily features new research reports on 16 major stocks, including TotalEnergies SE (TTE), America Movil, S.A.B. de C.V. (AMX) and Palo Alto Networks, Inc. (PANW).... Read Full Article

Returns Are Gaining Momentum At Laboratory Corporation of America Holdings (NYSE:LH)

Sat, 04 Mar 2023 13:25:37 To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...... Read Full Article

15 Companies that Just Started Paying Dividends

Thu, 02 Mar 2023 22:00:19 In this article, we discuss companies that just started paying dividends. You can skip our detailed analysis of dividend stocks and their importance, and go directly to read 5 Companies that Just Started Paying Dividends. The pandemic of 2020 took a toll ...... Read Full Article

Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking

Wed, 22 Feb 2023 14:00:00 BOSTON, February 22, 2023--Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app, which will now allow women to track menopause symptoms and access valuable resources and support to address the transition ...... Read Full Article

Laboratory Corporation of America Holdings (NYSE:LH) Q4 2022 Earnings Call Transcript

Mon, 20 Feb 2023 13:18:11 Laboratory Corporation of America Holdings (NYSE:LH) Q4 2022 Earnings Call Transcript February 16, 2023 Operator: Good day and thank you for standing by. Welcome to the Q4 and Full Year 2022 Labcorp Conference Call. Please be advised that today’s conference is being ...... Read Full Article

Laboratory Corporation of America Holdings Full Year 2022 Earnings: EPS Misses Expectations

Sat, 18 Feb 2023 12:15:47 Laboratory Corporation of America Holdings ( NYSE:LH ) Full Year 2022 Results Key Financial Results Revenue: US$14.9b...... Read Full Article

Labcorp vacates 177,000-square-foot Triad office building due to remote and hybrid work

Fri, 17 Feb 2023 20:01:21 The move comes at a time when the life sciences company has vacated approximately 650,000 square feet of commercial real estate across central North Carolina, according to Jim Anthony, CEO of APG Capital.... Read Full Article

Is It Smart To Buy Laboratory Corporation of America Holdings (NYSE:LH) Before It Goes Ex-Dividend?

Fri, 17 Feb 2023 10:09:17 Laboratory Corporation of America Holdings ( NYSE:LH ) stock is about to trade ex-dividend in 4 days. The ex-dividend...... Read Full Article

As it prepares for spin-off, Labcorp reports drop in Q4 and FY2022 revenues

Thu, 16 Feb 2023 18:29:25 Labcorp's revenue dropped in the fourth quarter and FY 2022, largely driven by the slowing demand for Covid-19 testing.... Read Full Article

LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Fall

Thu, 16 Feb 2023 16:00:04 The severe foreign exchange headwind, inflationary pressure and the ongoing Ukraine/Russia crisis impact LabCorp's (LH) business performance in Q4.... Read Full Article

Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders

Thu, 16 Feb 2023 15:41:00 Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after the public-health emergency ends.... Read Full Article

Labcorp reports 20% drop in COVID test sales in Q4

Thu, 16 Feb 2023 14:56:00 Shares of Laboratory Corporation of America Holdings (LH) were down about 2.9% in premarket trading on Thursday after the diagnostics company reported lower-than-expected revenue in the fourth quarter of 2022. Labcorp had earnings of $76.4 million, or 86 cents per share, in the fourth ...... Read Full Article

LabCorp (LH) Surpasses Q4 Earnings Estimates

Thu, 16 Feb 2023 13:35:01 LabCorp (LH) delivered earnings and revenue surprises of 1.97% and 2.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

UPDATE 2-Labcorp forecasts up to 90% fall in COVID testing sales in 2023

Thu, 16 Feb 2023 12:12:02 Laboratory Corp of America Holdings on Thursday predicted that COVID testing sales could fall by up to 90% this year after nearly two years of a boost to its diagnostics unit during the pandemic. The forecast echoes the fortune of other ...... Read Full Article

Labcorp Announces 2022 Fourth Quarter and Full-Year Results

Thu, 16 Feb 2023 12:00:00 BURLINGTON, N.C., February 16, 2023--Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.... Read Full Article

Labcorp considering $71 million aircraft base in Burlington

Tue, 14 Feb 2023 12:59:21 Specimen-transport fleet leads to possible big investment by Labcorp at Burlington Alamance airport. The city of Burlington has approved an economic incentive package for the project.... Read Full Article

Labcorp announces Fortrea as name for its planned clinical development spin-off

Thu, 09 Feb 2023 19:54:36 What could be the Triad's newest public company finally has a name: Fortrea (for-TREE-ah). A month after naming industry veteran Tom Pike as the future CEO and chairman, Labcorp announced Fortrea as the brand name of its planned clinical development ...... Read Full Article

Labcorp to spin off its clinical research organization under the name Fortrea

Thu, 09 Feb 2023 12:42:00 MARKET PULSE Labcorp (LH) said Thursday that it plans to spin off its clinical development business into a publicly traded clinical research organization, or CRO, in mid-2023. The name of the planned spin-off is Fortrea, and it will employ about 19,000 ...... Read Full Article
<